Article Information
History
- January 5, 2023.
Article Versions
- Version 1 (January 3, 2023 - 17:48).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Can Yue1,2,#,
- Weiliang Song2,3,4,#,
- Lei Wang1,
- Fanchong Jian1,2,5,
- Xiaosu Chen6,
- Fei Gao7,
- Zhongyang Shen8,
- Youchun Wang2,9,
- Xiangxi Wang1,2,* and
- Yunlong Cao2,3,*
- 1CAS Key Laboratory of Infection and Immunity, National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, P.R. China
- 2Changping Laboratory, Beijing, P.R. China
- 3Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing, P.R. China
- 4School of Life Sciences, Peking University, Beijing, P.R. China
- 5College of Chemistry and Molecular Engineering, Peking University, Beijing, P.R. China
- 6Frontier Research Center for Cell Response, Institute of Immunology, College of Life Sciences, Nankai University, Tianjin 300071, China
- 7Department of Pulmonary and Critical Care Medicine, The Fourth Hospital of Inner Mongolia, Hohhot 010058, China
- 8Organ Transplant Center, NHC Key Laboratory for Critical Care Medicine, Tianjin First Central Hospital, Nankai University, Tianjin 300192, China
- 9Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, P.R. China
- ↵*Correspondence: Xiangxi Wang (xiangxi{at}ibp.ac.cn), Yunlong Cao (yunlongcao{at}pku.edu.cn);
↵# These authors contributed equally.
Posted January 05, 2023.
Enhanced transmissibility of XBB.1.5 is contributed by both strong ACE2 binding and antibody evasion
